Peter Attia· MD
so i think for the foreseeable future it's there's going to be sort of this two two sort of main areas the way i think about applying these one is in the cancers that have no screening tests currently the bar is of course much lower right we we know that mammography even low-dose ct some you know uh mayor colonoscopy's a little bit of an exception but none of those are perfect obviously and yet we do them and at least for the case of lung cancer and the colon screening we're very confident they save lives we think for breast cancer i love crusades you know there's controversy around that but the um the in in the cases where we don't have screening tests if we can even get a test that's kind of like that not perfect but can get us some that could be helpful like it would be ideal in the case like pancreatic cancer but for reasons we talked about earlier but then we don't have the tree yeah we don't know what to do yeah we know what to do with them and i don't think that's the right place to do it but other cancers you know that we don't screen for um so there's that group and there may be the bar is lower because we don't have a predicate right